Analyst Ratings for Radient Pharmaceuticals (RPC)

RPC Rating Summary

  |   Expand Research on RPC
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 10 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/13/2017 BMO Capital N/A New Coverage Outperform
(N/A)
24.00
(N/A)
0.21
(0.21)
0% Details
10/7/2010 CapitalOne N/A New Coverage Overweight
(N/A)
N/A
(N/A)
0.68
(0.21)
-69.12% Details
Like RPC Ratings? Also take a look at

RPC Ratings News